Literature DB >> 15643992

Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival.

Hélady Sanders Pinheiro1, Niels Olsen Saraiva Câmara, Kikumi Suzete Osaki, Luiz Antonio Ribeiro De Moura, Alvaro Pacheco-Silva.   

Abstract

Accumulated oxalate will be excreted after renal transplantation, creating an increased risk of tubular precipitation, especially in the presence of allograft dysfunction. We evaluated calcium oxalate (CaOx) deposition in renal allograft biopsies with early dysfunction, its association with acute tubular necrosis (ATN) and graft survival. We studied 97 renal transplant patients, submitted to a graft biopsy within 3 months post-transplant, and reanalyzed them after 10 years. We analyzed renal tissue under polarized light and quantified CaOx deposits. CaOx deposits were detected in 52.6% of the patients; 26.8% were of mild and 25.8% of moderate intensity. The deposits were more frequent in biopsies performed within 3 weeks post-transplant (82.4 vs. 63.0%, p < 0.05) and in allografts with more severe renal dysfunction (creatinine 5.6 mg/dL vs. 3.4 mg/dL, p < 0.001). ATN incidence was also higher in patients with CaOx deposits (47% vs. 24%, p < 0.001). Twelve-year graft survival was strikingly worse in patients with CaOx deposits compared to those free of deposits (49.7 vs. 74.1%, p = 0.013). Our study shows a high incidence of CaOx deposits in kidney allografts with early dysfunction, implying an additional risk for acute tubular injury, with a negative impact on graft survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643992     DOI: 10.1111/j.1600-6143.2004.00684.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  24 in total

Review 1.  Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.

Authors:  Wacharee Seeherunvong; Myles Wolf
Journal:  Pediatr Transplant       Date:  2010-10-08

Review 2.  What is nephrocalcinosis?

Authors:  Linda Shavit; Philippe Jaeger; Robert J Unwin
Journal:  Kidney Int       Date:  2015-03-25       Impact factor: 10.612

3.  Oxalate nephropathy associated with chronic pancreatitis.

Authors:  Claire Cartery; Stanislas Faguer; Alexandre Karras; Olivier Cointault; Louis Buscail; Anne Modesto; David Ribes; Lionel Rostaing; Dominique Chauveau; Patrick Giraud
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

4.  Enteric Oxalate Secretion Mediated by Slc26a6 Defends against Hyperoxalemia in Murine Models of Chronic Kidney Disease.

Authors:  Laura I Neumeier; Robert B Thomson; Martin Reichel; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

5.  Posttransplant nephrocalcinosis is associated with poor renal allograft function: a single-center experience.

Authors:  Abdul Moiz; Tariq Javed; Jorge Garces; Adriana Dornelles; Catherine Staffeld-Coit
Journal:  Ochsner J       Date:  2015

Review 6.  Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.

Authors:  Kerstin Lorenz; Detlef K Bartsch; Juan J Sancho; Sebastien Guigard; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2015-10-02       Impact factor: 3.445

Review 7.  Clinical practice. Fibroblast growth factor (FGF)23: a new hormone.

Authors:  Uri S Alon
Journal:  Eur J Pediatr       Date:  2010-12-31       Impact factor: 3.183

8.  Transplantation outcomes in primary hyperoxaluria.

Authors:  E J Bergstralh; C G Monico; J C Lieske; R M Herges; C B Langman; B Hoppe; D S Milliner
Journal:  Am J Transplant       Date:  2010-09-17       Impact factor: 8.086

Review 9.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

10.  The effect of hypercalcemia on allograft calcification after kidney transplantation.

Authors:  Aygül Çeltik; Sait Şen; Mümtaz Yılmaz; Meltem Seziş Demirci; Gülay Aşçı; Abdülkerim Furkan Tamer; Banu Sarsık; Cüneyt Hoşcoşkun; Hüseyin Töz; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2016-08-13       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.